Washington Biotechnology Incorporated Company Profile

06:13 EST 22nd November 2017 | BioPortfolio

A Washington, D.C. based Contract Research Organization (CRO) offering In Vivo Preclinicals and Research, Quality Control, and Regulatory Services for United States FDA submissions.


6200 Freeport Centre
United States of America


Phone: 410-633-7449
Fax: 410-633-7478

News Articles [426 Associated News Articles listed on BioPortfolio]

#jobs #lifescience Washington University: Tenure Track Faculty Positions

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Washington University: Tenure Track Faculty Positions . To be determined: Was...

Vical Incorporated Announces Pricing of $25 Million Underwritten Public Offering of Common Stock

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock ...

"Road to Early Detection" Campaign Heads to Washington, D.C.

WASHINGTON , Sept. 8, 2017 /- Mobile MRI Unit coming to Washington DC When: Tuesday, September 12 th – Monday, September 18 th .The Brain Tumor Foundation (...

How George Washington’s teeth — from animals and maybe slaves — became an American legend

Washington’s teeth were crafted from gold leaf, lead plates, hippopotamus ivory, and the teeth of cows, horses, and, likely, Washington’s slaves.

APEC: Biotechnology Powerful Tool for Sustainable Agriculture

During the annual APEC High-Level Policy Dialogue on Agricultural Biotechnology (HLPDAB) Meeting in Can Tho, Vietnam on August 20, 2017, the agenda included agricultural biotechnology policies, promot...

OBD presents results of immunotherapy studies at FNIH Biomarker Consortium Cancer Steering Committee’s annual meeting

Oxford BioDynamics Plc, a biotechnology company focused on the discovery and development of epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotech...

Rigel Pharma: FDA Says Not Planning Of ODAC Meeting To Discuss Fostamatinibs NDA

WASHINGTON (dpa-AFX) - Rigel Pharmaceuticals, Inc. (RIGL), a biotechnology company, announced Monday an update on U.S. Food and Drug Administration review of Fostamatinib for immune thrombocytopen...

Biotechnology Stocks Repligen Major Breakout

Earlier this week we reported that biotechnology stocks are trying to break out. Exactly one day ago we published a hot tip in the biotechnology space, Repligen Corp, in our article 3 biotechnolog...

Clinical Trials [112 Associated Clinical Trials listed on BioPortfolio]

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

Registry Experience at the Washington Hospital Center, DES - Endeavor for Myocardial Infarction

Single-center registry of patients treated with at least one Endeavor, zotarolimus-eluting, Stent as the primary treatment for acute coronary syndrome at the Washington Hospital Center, wi...

Adjustable Gastric Band Survey Study

Our aim is to complete a survey study of patients who have undergone Adjustable Gastric Band (AGB) surgery at the University of Washington Medical Center (UWMC) and expanded to other baria...

Helping Individuals With Firearm Injuries

The investigators will conduct a cluster randomized trial of an intervention program that combines a hospital-based intervention, structured outreach program, and multi-agency attention. T...

Intervening to Prevent Youth Access to Marijuana Phase II

The legalization of recreational marijuana use and sales in Alaska, Colorado, Oregon, and Washington State is a dramatic change in U.S. substance abuse policy that places a priority on dev...

Companies [1419 Associated Companies listed on BioPortfolio]

The Washington Post

The Washington Post provides award-winning news and understanding about the politics, policies, personalities and institutions that make Washington, D.C. the world's seat of power...

Washington Biotechnology Incorporated

A Washington, D.C. based Contract Research Organization (CRO) offering In Vivo Preclinicals and Research, Quality Control, and Regulatory Services for United States FDA submissions.

Biotechnology Industry Organization and Washington Biotechnology and Biomedical Association

Washington Hospital Healthcare System

Washington Township Health Care District is governed by an elected board of directors. Unlike a municipal or county hospital, Washington Hospital’s operating expenses, resear...

Koronis Pharmaceuticals

Koronis was founded in 1998 to commercialize the original research of Drs. Larry Loeb and Jim Mullins, both at the University of Washington, and John Essigmann at the Massachusetts Institute of Techno...

More Information about "Washington Biotechnology Incorporated" on BioPortfolio

We have published hundreds of Washington Biotechnology Incorporated news stories on BioPortfolio along with dozens of Washington Biotechnology Incorporated Clinical Trials and PubMed Articles about Washington Biotechnology Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Washington Biotechnology Incorporated Companies in our database. You can also find out about relevant Washington Biotechnology Incorporated Drugs and Medications on this site too.

Quick Search

Relevant Topic

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Corporate Database Quicklinks

Searches Linking to this Company Record